As part of its mandate to regulate herbal medicines, the Food and Drugs Authority (FDA), organized a two-day training workshop for over eighty (80) Herbal Medicines practitioners under the sponsorship of the Department for International Development (DFID) a United Kingdom Government Department responsible for administering overseas aid.
The workshop, which took place on the August 28-29, 2017, was aimed at educating the Herbal Manufacturers on “Specifications for Herbal Products” with the aim of improving the overall quality, efficacy and product safety on the market.
It was also to expose participants to international standards and specifications for Herbal Products.
Specifications in regulation are set to confirm the quality of a product, a requirement that the FDA has realized most of the Industry players are finding difficulties to comply with.
Meanwhile, the FDA, requires that the manufacturers of herbal medicines meet certain condition to enable the FDA extend the current one year registration expiry on herbal medicines.
Opening the workshop on behalf of the Ag.CEO, the Ag. Deputy CEO of the Drugs Registration and Inspectorate Division, Mr. Seth Seaneke said, “the FDA is committed to actively engaging our stakeholders to ensure a collaborative effort towards ensuring safe, quality and efficacious products on the market.”
He also said that the willingness of the FDA to hold such training workshops for Herbal practitioners attests to the fact that the FDA has over the years helped improve the herbal medicine industry through capacity building activities such as the current training workshop.
It was in the light of this that the Drug Industrial Support Department (ISSD) of the FDA was established to provide technical support to industry.
He announce that to all its stakeholders that, aside ofthis specific training programme and other training programmes being organized by the FDA, companies can on their own, formally request for technical support.